| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Fuss Brands Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.06 |
| 52 Week High | US$1.10 |
| 52 Week Low | US$0.03 |
| Beta | 15.93 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -96.77% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| FBDS | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -6.1% | -3.5% |
| 1Y | n/a | -35.3% | 20.2% |
Return vs Industry: Insufficient data to determine how FBDS performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how FBDS performed against the US Market.
Price Volatility
| FBDS volatility | |
|---|---|
| FBDS Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FBDS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FBDS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 1 | Cheskel Meisels | www.fussbrands.com |
Fuss Brands Corp. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction. The company was formerly known as China Botanic Pharmaceutical Inc. and changed its name to Fuss Brands Corp. in July 2022.
Fuss Brands Corp. Fundamentals Summary
| FBDS fundamental statistics | |
|---|---|
| Market cap | US$1.15m |
| Earnings (TTM) | -US$483.13k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.4x
P/E RatioIs FBDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FBDS income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$483.13k |
| Earnings | -US$483.13k |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.025 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -60.1% |
How did FBDS perform over the long term?
See historical performance and comparison